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Abstract Various lipophilic cations, such as quinacrine mustard 
and dequalinium, which are known to inhibit mitochondrial 
F~-ATPase, strongly inhibited vacuolar H+-ATPase purified 
from bovine adrenal chromaffin granules. Quinacrine mustard 
bound irreversibly to vacuolar H+-ATPase suhunit A, and the 11 5 
kDa accessory polypeptide and dithiothreitol had no effect. The 
binding was competitively inhibited by chlorpromazine and quina- 
crine, and these compounds pecifically reduced the amount of 
labeling of subunit A. Quinacrine mustard also prevented the 
binding of [a-32p]ATP to subunit A but had no effect on the 
binding of [3H]N-ethylmaleimide to either subunit A or the 115 
kDa accessory polypeptide. These results suggest hat the binding 
site of quinacrine mustard in subunit A is not related to the 
N-ethylmaleimide-binding site(s), which is important for activity. 
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1. Introduction 
Vacuolar H+-ATPases (V-ATPases) transport protons into 
various organelles, including lysosomes, the Golgi apparatus, 
chromaffin granules and synaptic vesicles (for reviews, see 
[1-5]). The inside acidic pH and the transmembrane el ctro- 
chemical proton gradient hus established are essential for 
many cellular processes, uch as digestion of proteins in lyso- 
somes and concentration f amines and amino acids into synap- 
tic vesicles. 
The V-ATPases are composed of two different sectors: a 
hydrophilic V~ sector containing five different subunits (sub- 
units A-E) and a hydrophobic Vo sector containing at least five 
subunits [1-6]. It is generally accepted that V-ATPases have a 
similar subunit organization to FoF~ ATP synthase (F-ATP- 
ase): subunits A, B and c (16 kDa subunit) of V-ATPases have 
similar copy numbers and significant amino acid sequence ho- 
mologies to the t ,  ~ and c subunits of F-ATPase, respectively 
[1-5]. Similarities in the catalytic mechanisms of V- and F- 
ATPases have also been pointed out [7-9]. Moriyama and co- 
workers observed that chromaffin granule ATPase has ATP 
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binding sites with high and low affinities [7] and is modulated 
by ADP [8]. Furthermore, yeast V-ATPase shows unisite catal- 
ysis, suggesting the presence of similar catalytic ooperativity 
to that of F-ATPase [9]. A significant functional difference is, 
however, that V-ATPases have no ability to synthesize ATP 
coupled with H ÷ transport [1,10], whereas most F-ATPases 
function as ATP synthases. It is important to understand the 
molecular bases for the similarities and differences between 
these two types of ATPases. 
Inhibitors of both types of ATPases may provide an under- 
standing of their mechanistic similarities and differences, but 
only limited numbers of such inhibitors are known [2,3]. There- 
fore, in this study, we tested the effects of various lipophilic 
cations uch as quinacrine mustard and dequalinium, which are 
known inhibitors of mitochondrial F~-ATPase [11,12], on 
V-ATPase purified from bovine adrenal chromaffin granules. 
We found that the V-ATPase was also sensitive to these F~- 
ATPase inhibitors, and studied the mechanism of the inhibi- 
tion. 
2. Experimental 
V-ATPase with a specific activity of 3.0 U/mg protein was purified 
from chromaffin granules and reconstituted into liposomes by the 
method of Moriyama and Nelson [7,13]. Synaptic vesicles from rat 
brain [14] and vacuolar membrane vesicles from carrots and potatoes 
[15] were prepared by established procedures and stored at -70°C. 
F-ATPase was purified from over-producing Escherichia coli cells 
(DK8/pBWU 13) [16]. Quinacrine mustard and other lipophilic ations 
used in this study were purchased from Sigma. [3H]NEM (40 mCi/m 
mol) and [c~-32P]ATP (3000 Ci/mmol) were obtained from New England 
Nuclear and Amersham, respectively. Other reagents were the highest 
grade commercially available. 
Proteoliposomes containing purified V-ATPase were incubated at 
30°C for 10 min in 20 mM MOPS-Tris (pH 7.0) supplemented with 
0.1 M NaCI, 2 mM MgCI2 and 30/2M quinacrine mustard, washed 
three times with the buffer only and suspended in the buffer supple- 
mented with 0.1 M NaNO3, 2 mM MgCI2, and 4 mM ATP. The 
proteoliposome suspension was kept in an ice bath for 1 h with occa- 
sional mixing. This treatment released the hydrophilic VI sector from 
the proteoliposomes [17]. After centrifugation at 279,000 ×g for 1 h, the 
supernatant containing V~ was carefully separated and its fluorescence 
of quinacrine mustard was measured fluorometrically in 1 ml of 0.2 M 
MOPS-Tris (pH 8.0) with excitation and emission wave lengths of 275 
and 495 nm, respectively. 
Published methods were used for measuring ATPase activity [16], 
ATP-dependent formation of a pH gradient [14], labeling of V-ATPase 
subunits with [3H]NEM and [0~-32p]ATP [7], protein [18] and poly- 
acrylamide gel-electrophoresis in the presence ofsodium dodecyl sul- 
fate [7]. 
3. Results 
3.1. Lipophilic cations as V-ATPase inhibitors 
Allison and colleagues reported that a series of lipophilic 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  001 4-5793(95)0001 3-5 
70 Y. Moriyama et aL /FEBS Letters 359 (1995) 69-72 
1 2 3 4 
A 
1 2 
B 
cations inhibited Fi-ATPase [11,12]. We investigated the effects 
of the lipophilic cations on V-ATPase purified from bovine 
chromaffin granules in comparison with their effects on bacte- 
rial F-ATPase. These compounds inhibited both V- and F- 
ATPase at essentially the same concentrations and orders of 
effectiveness (Table 1). This is the first observation that lipo- 
philic cations inhibit V-ATPase. 
3.2. Characteristics of quinacrine mustard-induced inhibition 
Dequalinium and quinacrine mustard were strong inhibitors: 
4.4/tM dequalinium and 8.2/.tM quinacrine mustard caused 
50% inhibition (IDs0) of the activity of purified V-ATPase 
Fig. 1. Effect of quinacrine mustard on chemical modification of V- 
ATPase with [cz-32P]ATP or [3H]NEM. (A) Effect of quinacrine mustard 
on ATP-binding. Purified V-ATPase (3/.tg protein) in 50/21 of 20 mM 
MOPS-Tris (pH 7.0) buffer containing 5 mM monothioglycerol, 2 mM 
MgC12 and 0.3 ~tM [c~-32p]ATP was irradiated with UV light for 2 min 
in the presence of various inhibitors [4]. After dissociation of the en- 
zyme, the samples were subjected to 10% polyacrylamide g l-electro- 
phoresis in the presence of0.2% SDS. The gels were fixed and autora- 
diographed: lane 1, no inhibitor; lane 2, 0.1 mM NEM; lane 3, 20/IM 
quinacrine mustard; lane 4, 1 aM bafilomycin A1. (B) Effect of quina- 
crine mustard on NEM-binding. Purified V-ATPase (3 pg protein) was 
incubated in 50/11 of 20 mM MOPS-Tris (pH 7.0) buffer containing 
0.1 M NaCI and 50/IM [3H]NEM in the absence (lane 1) or presence 
(lane 2) of quinacrine mustard (50/~M). After incubation for 10 min 
at room temperature, actions were terminated by addition of the same 
buffer (10/11) containing 10% fl-mercaptoethanol and 10% SDS and the 
mixtures were subjected to polyacrylamide gel-electrophoresis. A 
fluorograph is shown. 
(.... 
(Table 1). Quinacrine mustard inhibited ATP-dependent pro- 
ton transport by V-ATPase from rat brain synaptic vesicles and 
plants vacuoles at similar concentrations (Table 2). However, 
dequalinium was required at a more than 10-fold higher con- 
centration for 50% inhibition of the transport and ATPase 
activity in synaptic and plant vesicles (data not shown). There- 
fore, we concentrated on the mode of inhibition of V-ATPases 
by quinacrine mustard. 
The ATPase activity inhibited by quinacrine mustard was not 
restored by extensive washing of proteoliposomes with 10 mM 
MOPS-Tris buffer (pH 7.0) containing 2 mM MgC12 and 5 mM 
thioglycerol, indicating that quinacrine mustard bound to the 
enzyme irreversibly. The other compounds listed in Table 1 
inhibited the enzyme reversibly. 
Quinacrine and chlorpromazine were much less inhibitory. 
However, they lowered the inhibition by quinacrine mustard. 
After incubation of V-ATPase with quinacrine mustard 
(30/.tM) in the presence or absence of quinacrine (5 mM) and 
chlorpromazine (1 mM), the enzyme was diluted 20-fold and 
the ATPase activity was measured: 57 and 63% of the activities, 
respectively remained, whereas only 10% of the activity re- 
mained after incubation without quinacrine or chlorpromazine. 
Quinacrine mustard prevented the binding of [c~-32P]ATP to 
subunit A (Fig. 1A). Similar inhibition of the labeling was 
observed with NEM, the binding site of which is in subunit A, 
but neither bafilomycin A~ nor N,N'-dicyclohexylcarbodiim- 
Table 1 
Inhibitions (IDa0; /IM) of V- and F-ATPases by various lipophilic 
cations 
Reagent V-ATPase F-ATPase 
Quinacrine mustard 8.2 5.3 
Quinacrine 930 580 
Dequalinium 4.4 24 
Acridine orange 270 68 
Brilliant green 170 27 
Rhodamine 6G 315 34 
Safranine O 450 330 
Pyronin Y 78 70 
Rhodamine 123 1500 580 
The ATPase activities of purified V-ATPase or bacterial F-ATPase 
were measured with at least seven different concentrations of the listed 
lipophilic ations, and results are expressed asIDs0 values (concentra- 
tions required for 50% inhibition). 
I 2 ide, known to bind to V0 subunits [8,9], inhibited the labeling 
(Fig. 1A). Quinacrine mustard had no effect on the binding of 
[3H]NEM to subunit A (Fig. 1 B) and the inactivation by quina- 
crine mustard was not affected by dithiothreitol (0.5 mM), 
indicating that a cysteine residue(s) in subunit A is not involved 
in the inhibition by quinacrine mustard. 
3.3. Labeling of  subunit A by quinacrine mustard 
To confirm that subunit A is the binding site(s) for quinacrine 
mustard, V-ATPase inactivated with 30 pM quinacrine mus- 
tard was dissociated and applied to a polyacrylamide g l, and 
the subunits labeled with quinacrine mustard were located. We 
found that subunit A and a 115 kDa accessory subunit were the 
proteins predominantly abeled fluorescently with the reagent 
(Fig. 2, lane 1), whereas essentially no quinacrine mustard flu- 
orescence was detectable in other subunits. Quinacrine (5 mM) 
(Fig. 2, lane 2) or chlorpromazine (1 raM) (data not shown) 
reduced the binding of quinacrine mustard to subunit A and its 
inhibition of ATPase activity. These results suggested that the 
binding of quinacrine mustard to subunit A, but not to the 
115 kDa polypeptide, inhibited the enzyme. 
The labeled V~ sector was prepared by cold treatment [17], 
and quinacrine mustard in subunit A was measured fluoromet- 
rically: about 2.7 nmol of quinacrine mustard bound to 1 nmol 
of V~ sector. Quinacrine mustard bound with the 115 kDa 
polypeptide that remained in the membrane sector, consistent 
with the intrinsic membrane location of this subunit [7]. These 
results suggested that 3 mol of quinacrine mustard bound per 
mol of V1 sector, suggesting that incorporation of 1 tool of 
quinacrine mustard per mol of subunit A caused complete inac- 
tivation. 
4. Discussion 
The effects of lipophilic cations on V-ATPase have been 
estimated previously using organellar membrane preparations. 
The results were, however, discrepant depending on the prepa- 
ration, because V-ATPase is not the only enzyme hydrolyzing 
ATP [19]. For instance, chlorpromazine and tricyclic antide- 
pressant inhibited partially purified chromaffin granule ATP- 
ase [20,21], and antimalarial gents uch as chloroquine inhib- 
ited lysosomal ATPase [22]. However, we showed recently that 
these lipophilic ations are less inhibitory to purified V-ATPase 
even at mM concentrations [23]. Here, we found that a group 
of lipophilic cations, and especially quinacrine mustard, 
strongly inhibited V-ATPase as well as F-ATPase. 
The mode of inhibition of V-ATPases by quinacrine mustard 
Table 2 
Inhibitions of V-ATPases from various ources by quinacrine mustard 
Vacuolar membranes IDs0 (//M) 
Rat brain synaptic vesicles 4.8 
Carrot vacuolar membrane vesicles 5.0 
Potato vacuolar membrane vesicles 3.5 
ATP-dependent H÷ transports in various vacuolar membranes were 
assayed by acridine orange fluorescence quenching in the presence of 
various concentrations of quinacrine mustard. Results are expressed as 
IDs0 values. With plant vacuolar membrane vesicles, vanadate (0.2 
mM) and EGTA (0.1 mM) were added to inhibit plasma membrane 
H*-ATPase (P-type ATPase) and CaZ+/H +, respectively, although con- 
taminations of the plasma membrane vesicles were negligible. 
115kDa - 
subunit A - 
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Fig. 2. Detection of V-ATPase subunits labeled with quinacrine mus- 
tard. Reconstituted V-ATPase proteoliposomes (3 ~tg protein) were 
incubated in 50 pl of 20 mM MOPS-Tris (pH 7.0) buffer containing 
0.1 M NaCI, 2 mM MgCI2 and 30/tM quinacrine mustard in the 
absence (lane 1) or presence (lane 2) of quinacrine (5 mM) for 10 min 
at room temperature. Reactions were terminated by adding 10 pl of 20 
mM Tris-C1 (pH 8.8) containing 10% SDS and the mixtures were 
subjected to polyacrylamide g l-electrophoresis. The gels were soaked 
in 0.1 M Tris-Cl (pH 8.8) and quinacrine mustard bound to the subunits 
was detected under UV light. Positions of subunits were identified in 
gels stained with Commassie brilliant blue. 
was similar to that of inhibition of mitochondrial F,-ATPase: 
the inhibition was irreversible, partially protected by chlorpro- 
mazine or quinacrine and was due to stoichiometric binding to 
the catalytic subunit [11]. These results suggested that quina- 
crine mustard has similar binding sites in F- and V-ATPases 
and blocks a catalytic pathway common to the two. Allison et 
al. reported that quinacrine mustard bound to a cluster of 
anionic amino acids (DELSEED) in the catalytic fl subunit of 
mitochondrial F-ATPase [24]. This region corresponds to 
ASLAETD (residues 499-505) in subunit A of bovine brain 
V-ATPase (identical residues underlined) [25], and may be a 
quinacrine mustard-binding site in subunit A. It is noteworthy 
that this region is different from a putative nucleotide binding 
domain (bovine residues 250-257) or a cysteine residue(s) con- 
ferring NEM sensitivity [25]. Consistent with this possibility, 
the present results suggest that the binding site for quinacrine 
mustard is different from that of the ATP or NEM-binding 
domain in subunit A. 
This work showed that quinacrine mustard and other lipo- 
philic cations are strong inhibitors of V- and F-ATPases. These 
compounds will be useful to probe the molecular mechanism 
common to both types of ATPase. Furthermore, derivatives of 
these compounds may have selective toxicities on V-ATPases 
of non-mammalian species uch as fungi and protozoa. 
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